Back to search results

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

Abroad (travel likely)RecruitingPHASE2

Conditions

Extensive-stage Small-cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Jincheng General Hospital, Jincheng, Shanxi, China

    Contact: Study coordinator (Xueqin Li, Dr.) · +86 356 3661360

  • Jinzhong third people's hospital, Jinzhong, Shanxi, China

    Contact: Study coordinator (Qian Wu, Dr.) · +86 354 3532157

  • Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

    Contact: Study coordinator (Gang Jin, Dr.) · +86 351 3365422

  • Shanxi Bethune Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Huijing Feng, Dr.) · +86 351 8368114

  • Shanxi Hospital of Traditional Chinese Medicine, Taiyuan, Shanxi, China

    Contact: Study coordinator (Jinyang Bai, Dr.) · +86 351 303009

  • TISCO General Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Weihua Jia, Dr.) · +86 351 3012448
Study leads

  • Gang Jin, Dr.

    Principal Investigator

    Second Hospital of Shanxi Medical University

View source on ClinicalTrials.gov(opens in a new tab)